Skip to content

Mediacenter

Interaktiv & Videos

CytoSorb Therapy in critically ill COVID-19 patients – actual results and best practice | Webinar 1
1/8 videos
1
Best Bits | International Expert Meeting | Intensive Care | Manu Malbrain
Best Bits | International Expert Meeting | Intensive Care | Manu Malbrain
02:32
2
Best Bits | International Expert Meeting | Intensive Care | Axel Nierhaus
Best Bits | International Expert Meeting | Intensive Care | Axel Nierhaus
02:25
3
International Experts Meeting | Intensive Care | Full Version | Webinar 1
International Experts Meeting | Intensive Care | Full Version | Webinar 1
01:37:05
4
Internationales Expertentreffen | Intensivmedizin | Vollversion | Webinar 1
Internationales Expertentreffen | Intensivmedizin | Vollversion | Webinar 1
01:37:05
5
Reunión internacional de expertos | Cuidados Intensivos | Versión completa | Webinar 1
Reunión internacional de expertos | Cuidados Intensivos | Versión completa | Webinar 1
01:37:05
6
Cytokine storm in COVID-19 – are we sure about it? | Didier Payen | Webinar 1
Cytokine storm in COVID-19 – are we sure about it? | Didier Payen | Webinar 1
07
7
Overview about current data and latest findings | Axel Nierhaus | Webinar 1
Overview about current data and latest findings | Axel Nierhaus | Webinar 1
18:26
8
In whom and when to start? Useful tools and practical hints | Manu Malbrain | Webinar 1
In whom and when to start? Useful tools and practical hints | Manu Malbrain | Webinar 1
13:12
Video abspielen
Video abspielen
Video abspielen

Interaktiv & Videos

SIP OF SCIENCE WITH ZSOLT
1/1 videos
1
SIP OF SCIENCE WITH ZSOLT insights into recent publications | No. 1
SIP OF SCIENCE WITH ZSOLT insights into recent publications | No. 1
40:47
CytoSorb Therapy in Acute on Chronic Liver Failure | Webinar 1
1/6 videos
1
CytoSorb Therapy in Acute on Chronic Liver Failure | Liver | Full Version | Webinar 1
CytoSorb Therapy in Acute on Chronic Liver Failure | Liver | Full Version | Webinar 1
01:31:12
2
CytoSorb Therapy in Acute on Chronic Liver Failure | Leber | Vollversion | Webinar 1
CytoSorb Therapy in Acute on Chronic Liver Failure | Leber | Vollversion | Webinar 1
01:31:12
3
Terapia CytoSorb en la fallahepática aguda y crónica | HÍGADO | Versión completa | Webinar 1
Terapia CytoSorb en la fallahepática aguda y crónica | HÍGADO | Versión completa | Webinar 1
01:31:12
4
Background and rationale | Frederik Brozat | Liver Webinar No. 1 | 2021
Background and rationale | Frederik Brozat | Liver Webinar No. 1 | 2021
10:46
5
What are the clinical benefits? | Matthias Schneeweiss | Liver Webinar No. 1 | 2021
What are the clinical benefits? | Matthias Schneeweiss | Liver Webinar No. 1 | 2021
11:32
6
Do we have a new method to reduce ammonia? | Stefan Buettner | Liver Webinar No. 1 | 2021
Do we have a new method to reduce ammonia? | Stefan Buettner | Liver Webinar No. 1 | 2021
08:34
ECMO und CytoSorb –Nice to have oder doch ein Must have? | Webinar 2021
1/1 videos
1
ECMO und CytoSorb –Nice to have oder doch ein Must have? | Webinar 2021
ECMO und CytoSorb –Nice to have oder doch ein Must have? | Webinar 2021
01:22
Herzmedizin 2021 Digital
1/2 videos
1
Die CytoSorb-Therapie in der Herzchirurgie - neue Daten und klinische Ergebnisse | DGTHG 2021
Die CytoSorb-Therapie in der Herzchirurgie - neue Daten und klinische Ergebnisse | DGTHG 2021
57:39
2
CytoSorb therapy in cardiac surgery - New data and clinical results | DGTHG 2021
CytoSorb therapy in cardiac surgery - New data and clinical results | DGTHG 2021
57:39
Behandlung von Hyperinflammation und anderen Komplikationen nach einem herzchirugischen Eingriff | Webinar 3
1/4 videos
1
Internationales Expertentreffen | Herzchirurgie | Vollversion | Webinar 3
Internationales Expertentreffen | Herzchirurgie | Vollversion | Webinar 3
01:23:47
2
Wie wir CytoSorb in der täglichen Routine einsetzen | Lars-Uwe Kühne | Webinar 3
Wie wir CytoSorb in der täglichen Routine einsetzen | Lars-Uwe Kühne | Webinar 3
11:01
3
ECMO in Kombination mit CytoSorb: Wann, wie und warum? | Leonardo Gottin | Webinar 3
ECMO in Kombination mit CytoSorb: Wann, wie und warum? | Leonardo Gottin | Webinar 3
14:43
4
Herausforderung Rhabdomyolyse - Es gibt eine neue Behandlungsoption | Udo Boeken | Webinar 3
Herausforderung Rhabdomyolyse - Es gibt eine neue Behandlungsoption | Udo Boeken | Webinar 3
07:21
Verbesserung des chirurgischen Outcome bei Hochrisiko Herzpatienten | Webinar No. 2
1/2 videos
1
Patienten mit infektiöser Endokarditis: Meine klinischen Erfahrungen | Daniel Wendt | Webinar 2
Patienten mit infektiöser Endokarditis: Meine klinischen Erfahrungen | Daniel Wendt | Webinar 2
17:08
2
Patienten in der Aortenchirurgie: Meine klinischen Erfahrungen | Dr. Yatin Mehta | Webinar 2 | 2021
Patienten in der Aortenchirurgie: Meine klinischen Erfahrungen | Dr. Yatin Mehta | Webinar 2 | 2021
09:26
Reduce bleeding complications in ticagrelor and rivaroxaban treated patients undergoing emergency Cardiac Surgery | Webinar No. 1
1/4 videos
1
Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
02:49
2
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
13:07
3
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
12:17
4
Why is it relevant? | Robert F Storey | Webinar 1 | 2021
Why is it relevant? | Robert F Storey | Webinar 1 | 2021
08:50
DIVI 2020 | Virtuelles CytoSorbents Symposium
1/5 videos
1
Covid-19 und septischer Schock – Welche Gemeinsamkeiten und Unterschiede gibt es? | Axel Nierhaus
Covid-19 und septischer Schock – Welche Gemeinsamkeiten und Unterschiede gibt es? | Axel Nierhaus
17:43
2
Das richtige Timing für einen Therapiebeginn in der Sepsis | Klaus Kogelmann | DIVI 2020
Das richtige Timing für einen Therapiebeginn in der Sepsis | Klaus Kogelmann | DIVI 2020
15:20
3
Warum wir eine individuelle Dosisanpassung brauchen | Thomas Köhler | DIVI 2020
Warum wir eine individuelle Dosisanpassung brauchen | Thomas Köhler | DIVI 2020
15:32
4
Medikamentenentfernung – was wir bisher wissen | Steffen Mitzner | DIVI 2020
Medikamentenentfernung – was wir bisher wissen | Steffen Mitzner | DIVI 2020
14:25
5
Der besondere Fall - Herausforderung fulminante Leptospirose | Achim Jörres | DIVI 2020
Der besondere Fall - Herausforderung fulminante Leptospirose | Achim Jörres | DIVI 2020
11:03
Virtuelles 7. deutschsprachiges CytoSorb Anwendertreffen | Berlin | 2020
1/19 videos
1
Begrüssung | Christian Steiner
Begrüssung | Christian Steiner
08:27
2
Begrüssung | Stefan Baudis
Begrüssung | Stefan Baudis
06:48
3
DOKU 7. CytoSorb Anwendertreffen D-A-CH
DOKU 7. CytoSorb Anwendertreffen D-A-CH
04:31
4
Langzeit-Follow-up von Patienten mit septischem Schock unter CytoSorb-Behandlung  | W. P. Brouwer
Langzeit-Follow-up von Patienten mit septischem Schock unter CytoSorb-Behandlung | W. P. Brouwer
12:30
5
Long term outcome in septic shock patients – results of an actual study | W. P. Brouwer
Long term outcome in septic shock patients – results of an actual study | W. P. Brouwer
12:31
6
CytoSorb im septischen Schock - neueste Daten aus Österreich | Berthold Bein
CytoSorb im septischen Schock - neueste Daten aus Österreich | Berthold Bein
03:56
7
Das richtige Timing - der CytoScore als Entscheidungshilfe | Klaus Kogelmann
Das richtige Timing - der CytoScore als Entscheidungshilfe | Klaus Kogelmann
13:53
8
Das richtige Dosing – hat ein häufiger Adsorberwechsel Einfluss auf das Outcome? | Thomas Köhler
Das richtige Dosing – hat ein häufiger Adsorberwechsel Einfluss auf das Outcome? | Thomas Köhler
14:07
9
Nach über 1.000 Patienten – Aktuelles über das CytoSorb-Register | Frank Brunkhorst
Nach über 1.000 Patienten – Aktuelles über das CytoSorb-Register | Frank Brunkhorst
18:45
10
Unterschiede und Ähnlichkeiten zu Patienten im septischen Schock | Axel Nierhaus
Unterschiede und Ähnlichkeiten zu Patienten im septischen Schock | Axel Nierhaus
11:47
11
COVID-19 - Was wir gelernt haben | Andreas Faltlhauser
COVID-19 - Was wir gelernt haben | Andreas Faltlhauser
20:24
12
ECMO | 7. CytoSorb Anwendertreffen D-A-CH | Daniel Dürschmied
ECMO | 7. CytoSorb Anwendertreffen D-A-CH | Daniel Dürschmied
12:59
13
CytoSorb als Leberunterstützungstherapie - Was wir bisher wissen | Jan Stange
CytoSorb als Leberunterstützungstherapie - Was wir bisher wissen | Jan Stange
13:46
14
Herausforderung: Akut auf chronisches Leberversagen | Johathan Frederik Brozat, Alexander Koch
Herausforderung: Akut auf chronisches Leberversagen | Johathan Frederik Brozat, Alexander Koch
13:16
15
Kombination aus Sepsis und akutem Leberversagen nach Sectio | Robert Breitkopf
Kombination aus Sepsis und akutem Leberversagen nach Sectio | Robert Breitkopf
10:06
16
Fluminante Leptospirose | Achim Jörres
Fluminante Leptospirose | Achim Jörres
09:04
17
Hämolytisch-urämisches Syndrom (HUS) | Stephan Ziegeler
Hämolytisch-urämisches Syndrom (HUS) | Stephan Ziegeler
08:39
18
Tumorlysesyndrom mit Leberversagen  | Bartosz Tycszynski, Essen
Tumorlysesyndrom mit Leberversagen | Bartosz Tycszynski, Essen
10:08
19
Schlussworte 7. CytoSorb Anwendertreffen D-A-CH | Christian Steiner & Stefan Baudis
Schlussworte 7. CytoSorb Anwendertreffen D-A-CH | Christian Steiner & Stefan Baudis
07:04
Kardiotechnikertagung der DGfK & DGTHG | Satelliten Symposium | Berlin | 2020
1/6 videos
1
Herausforderung Endokarditis | Prof. Karl Träger, Ulm | Virtuelle Kardiotechnikertagung 2020
Herausforderung Endokarditis | Prof. Karl Träger, Ulm | Virtuelle Kardiotechnikertagung 2020
07:21
2
Herausforderung Endokarditis | Stefan Sajgo, Ulm | Virtuelle Kardiotechnikertagung 2020
Herausforderung Endokarditis | Stefan Sajgo, Ulm | Virtuelle Kardiotechnikertagung 2020
07:51
3
Warum eine Kombination mit ECMO sinnvoll ist | Dr. Alexander Supady, Freiburg
Warum eine Kombination mit ECMO sinnvoll ist | Dr. Alexander Supady, Freiburg
09:53
4
Warum eine Kombination mit ECMO sinnvoll ist | Prof. Christoph Benk, Freiburg
Warum eine Kombination mit ECMO sinnvoll ist | Prof. Christoph Benk, Freiburg
03:51
5
Entfernung von Ticagrelor und Rivaroxaban zur Vermeidung von Komplikationen und Kosten | K. Hassan
Entfernung von Ticagrelor und Rivaroxaban zur Vermeidung von Komplikationen und Kosten | K. Hassan
08:35
6
Entfernung von Ticagrelor und Rivaroxaban zur Vermeidung von Komplikationen und Kosten | H. Pioch
Entfernung von Ticagrelor und Rivaroxaban zur Vermeidung von Komplikationen und Kosten | H. Pioch
06
7th International CytoSorb Users` Meeting | 2020
1/17 videos
1
Welcome | Stefan Baudis & Christian Steiner | 7th International CytoSorb Users` Meeting | 2020
Welcome | Stefan Baudis & Christian Steiner | 7th International CytoSorb Users` Meeting | 2020
12:37
2
The Rotterdam study – long term outcome in septic shock patients | Can Ince | 7th IUM |  2020
The Rotterdam study – long term outcome in septic shock patients | Can Ince | 7th IUM | 2020
11:12
3
Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski | 7th IUM | 2020
Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski | 7th IUM | 2020
09:08
4
The International CytoSorb Registry | Frank Brunkhorst | 7th International CytoSorb Users` Meeting |
The International CytoSorb Registry | Frank Brunkhorst | 7th International CytoSorb Users` Meeting |
15:23
5
The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann | 7th IUM | 2020
The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann | 7th IUM | 2020
13:16
6
Liver support on a higher level – what we already know | Mihai Popescu | 7th IUM | 2020
Liver support on a higher level – what we already know | Mihai Popescu | 7th IUM | 2020
10:34
7
The right anticoagulation – we have a lot of options | Gilda Cinnella | 7th IUM | Berlin | 2020
The right anticoagulation – we have a lot of options | Gilda Cinnella | 7th IUM | Berlin | 2020
20:17
8
Update on drug removal – more pros than cons | Steffen Mitzner | 7th IUM | Berlin | 2020
Update on drug removal – more pros than cons | Steffen Mitzner | 7th IUM | Berlin | 2020
15:09
9
Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus | 7th IUM | Berlin | 2020
Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus | 7th IUM | Berlin | 2020
21:27
10
Experiences from Italy | Giorgio Berlot | 7th International CytoSorb Users` Meeting | Berlin | 2020
Experiences from Italy | Giorgio Berlot | 7th International CytoSorb Users` Meeting | Berlin | 2020
12:21
11
Experiences from Iran | Amir Ahmad Nassiri | 7th International CytoSorb Users` Meeting | 2020
Experiences from Iran | Amir Ahmad Nassiri | 7th International CytoSorb Users` Meeting | 2020
17:01
12
Experiences from the US | Michael Firstenberg | 7th International CytoSorb Users` Meeting | 2020
Experiences from the US | Michael Firstenberg | 7th International CytoSorb Users` Meeting | 2020
12:18
13
Experiences from Latin America | José Ernesto López Almaraz | 7th IUM | Berlin | 2020
Experiences from Latin America | José Ernesto López Almaraz | 7th IUM | Berlin | 2020
14:59
14
Complex case of TTP associated with severe pancreatitis | Stephan Ziegeler | 7th IUM | Berlin | 2020
Complex case of TTP associated with severe pancreatitis | Stephan Ziegeler | 7th IUM | Berlin | 2020
09:21
15
Cytokine release syndrome after CAR-T-Cell therapy | Gabriella Bottari | 7th IUM | Berlin | 2020
Cytokine release syndrome after CAR-T-Cell therapy | Gabriella Bottari | 7th IUM | Berlin | 2020
08:37
16
MDMA intoxication | Alexander Supady | 7th International CytoSorb Users` Meeting | Berlin | 2020
MDMA intoxication | Alexander Supady | 7th International CytoSorb Users` Meeting | Berlin | 2020
06:40
17
Closing remarks | Efthymios Deliargyris | 7th International CytoSorb Users` Meeting | Berlin | 2020
Closing remarks | Efthymios Deliargyris | 7th International CytoSorb Users` Meeting | Berlin | 2020
10:35
EACTS | 2020
1/5 videos
1
CytoSorbents Introduction | EACTS 2020
CytoSorbents Introduction | EACTS 2020
02:34
2
Mitral valve endocarditis – new chances to improve the outcome | Daniel Wendt | EACTS 2020
Mitral valve endocarditis – new chances to improve the outcome | Daniel Wendt | EACTS 2020
21:13
3
Aortic surgery – modulation of the inflammatory response | Yatin Mehta | EACTS 2020
Aortic surgery – modulation of the inflammatory response | Yatin Mehta | EACTS 2020
10:40
4
Removal of Ticagrelor during emergency heart surgery  | Stephan Geidel | EACTS 2020
Removal of Ticagrelor during emergency heart surgery | Stephan Geidel | EACTS 2020
19:48
5
Successful treatment of rhabdomyolysis following heart transplantation | Udo Boeken | EACTS 2020
Successful treatment of rhabdomyolysis following heart transplantation | Udo Boeken | EACTS 2020
12:20
COVID-19 and CytoSorb Therapy | Webinar
1/3 videos
1
Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb
Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb
01:31:26
2
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
01:13:57
3
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar
01:01:52
DIVI | 2019 | Hamburg
1/4 videos
1
Schnelle Schockkontrolle in der Sepsis | DIVI | 2019 | Hamburg
Schnelle Schockkontrolle in der Sepsis | DIVI | 2019 | Hamburg
17:27
2
Ein früher Therapiebeginn kann das Outcome verbessern | DIVI | 2019 | Hamburg
Ein früher Therapiebeginn kann das Outcome verbessern | DIVI | 2019 | Hamburg
13:12
3
ECMO plus CytoSorb | DIVI | 2019 | Hamburg
ECMO plus CytoSorb | DIVI | 2019 | Hamburg
13:56
4
Medikamentendosierung unter CytoSorb: Anpassungen erforderlich | DIVI 2019 | Hamburg
Medikamentendosierung unter CytoSorb: Anpassungen erforderlich | DIVI 2019 | Hamburg
21:34
6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
1/10 videos
1
Bedeutung der Hämodynamik und Konsequenzen hoher Katecholamindosierungen | Berthold Bein
Bedeutung der Hämodynamik und Konsequenzen hoher Katecholamindosierungen | Berthold Bein
20:18
2
CytoSorb zur Kreislaufstabilisierung im vasoplegischen Schock | Karl Träger
CytoSorb zur Kreislaufstabilisierung im vasoplegischen Schock | Karl Träger
22:02
3
Wann beginne ich die Therapie? CytoScore als neue Möglichkeit... | Klaus Kogelmann
Wann beginne ich die Therapie? CytoScore als neue Möglichkeit... | Klaus Kogelmann
17:48
4
Aktuelle Daten zur Sicherheit und Antibiotika-Dosierung unter CytoSorb | Steffen Mitzner
Aktuelle Daten zur Sicherheit und Antibiotika-Dosierung unter CytoSorb | Steffen Mitzner
31:31
5
Das CytoSorb-Register – Eine aktuelle Zwischenauswertung | Daniel Dürschmied
Das CytoSorb-Register – Eine aktuelle Zwischenauswertung | Daniel Dürschmied
06:42
6
CytoSorb und Pruritus | Markus Tölle | 6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
CytoSorb und Pruritus | Markus Tölle | 6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
17:45
7
CytoSorb zur Myoglobin-Entfernung | Stephan Klösel
CytoSorb zur Myoglobin-Entfernung | Stephan Klösel
18:24
8
CytoSorb und ECMO - Erfahrungen aus Freiburg | Alexander Supady
CytoSorb und ECMO - Erfahrungen aus Freiburg | Alexander Supady
17:06
9
CytoSorb und ECMO - Erfahrungen aus Ibbenbüren | Stephan Ziegeler
CytoSorb und ECMO - Erfahrungen aus Ibbenbüren | Stephan Ziegeler
13:46
10
CytoSorb beim Leberversagen – Rationale und Übersicht der bisherigen Daten | Jan Stange
CytoSorb beim Leberversagen – Rationale und Übersicht der bisherigen Daten | Jan Stange
13:29
EACTS | 2019 | Lisbon | Symposium
1/17 videos
1
Enhanced hemodynamic and metabolic stability in aortic surgery | EACTS | 2019 | Lisbon |
Enhanced hemodynamic and metabolic stability in aortic surgery | EACTS | 2019 | Lisbon |
14:20
2
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
18:29
3
Intraoperative use in endocarditis -The REMOVE trial | EACTS | 2019 | Lisbon |
Intraoperative use in endocarditis -The REMOVE trial | EACTS | 2019 | Lisbon |
17:20
4
Faster control of refractory vasoplegic shock | Nandor Marczin | EACTS 2019
Faster control of refractory vasoplegic shock | Nandor Marczin | EACTS 2019
22:45
5
6
Effects on outcome in mitral valve infective endocarditis | Daniel Wendt | EACTS 2019
Effects on outcome in mitral valve infective endocarditis | Daniel Wendt | EACTS 2019
15:26
7
Reduction of inflammation in heart transplantation | Endre Németh | EACTS | 2019 | Lisbon
Reduction of inflammation in heart transplantation | Endre Németh | EACTS | 2019 | Lisbon
17:27
8
Removal of Ticagrelor | Stephan Geidel | EACTS 2019
Removal of Ticagrelor | Stephan Geidel | EACTS 2019
20:12
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019
13:22
10
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
11
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
12
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
13
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
14
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Polish Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Polish Subtitles
13:22
15
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
16
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
17
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
EACTS | 2019 | Lisbon | Symposium mit Untertiteln
1/9 videos
1
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | French Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | French Subtitles
15:30
2
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
3
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
4
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Polish Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Polish Subtitles
15:30
5
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
6
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
7
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
8
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
ESICM Lives 2019 | Berlin
1/7 videos
1
Improved outcome of patients in septic shock | ESICM Lives 2019: Webcast
Improved outcome of patients in septic shock | ESICM Lives 2019: Webcast
24:20
2
3
What makes it unique Rationale of CytoSorb | ESICM Lives 2019: Webcast
What makes it unique Rationale of CytoSorb | ESICM Lives 2019: Webcast
20:10
4
Drug removal and safety aspects – what do we currently know | ESICM Lives 2019: Webcast
Drug removal and safety aspects – what do we currently know | ESICM Lives 2019: Webcast
18:01
5
Improved outcome of patients in septic shock | ESICM Lives 2019: Summary
Improved outcome of patients in septic shock | ESICM Lives 2019: Summary
01:53
6
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
21:27
7
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
21:27
Sepsis Update 2019 | Weimar | Symposium Webcast
1/4 videos
1
Hemodynamic changes during hemoadsorption – Which parameters matter | Sepsis Update 2019
Hemodynamic changes during hemoadsorption – Which parameters matter | Sepsis Update 2019
18:06
2
Timing and dosing as part of an individualized therapy in septic shock | Sepsis Update 2019
Timing and dosing as part of an individualized therapy in septic shock | Sepsis Update 2019
16:04
3
How we use CytoSorb in clinical routine | Sepsis Update 2019
How we use CytoSorb in clinical routine | Sepsis Update 2019
11:24
4
What makes it unique? Rationale and background of CytoSorb Therapy | Sepsis Update 2019
What makes it unique? Rationale and background of CytoSorb Therapy | Sepsis Update 2019
14:22
TCS ECMO 2019 | Paris | Symposium Webcast
1/2 videos
1
TCS ECMO 2019 | Paris | Webcast Pappalardo
TCS ECMO 2019 | Paris | Webcast Pappalardo
11:53
2
TCS ECMO 2019 | Paris | Webcast Traeger
TCS ECMO 2019 | Paris | Webcast Traeger
27:23
6th International CytoSorb Users` Meeting | 2019 | Brussels
1/10 videos
1
Welcome - 6th International CytoSorb Users` Meeting
Welcome - 6th International CytoSorb Users` Meeting
09:06
2
My very special CytoSorb case
My very special CytoSorb case
11:16
3
My clinical experiences after 100 patients
My clinical experiences after 100 patients
11:48
4
From experiments to evidence: Safety aspects and drug removal
From experiments to evidence: Safety aspects and drug removal
46:58
5
Hemoadsorption modulates pulmonary metabolism and edema formation
Hemoadsorption modulates pulmonary metabolism and edema formation
11:56
6
CytoSorb in cardiac arrest
CytoSorb in cardiac arrest
11:08
7
CytoScore helps me to find the right starting point
CytoScore helps me to find the right starting point
10:26
8
Opening Lecture: Past, present and future of CytoSorb
Opening Lecture: Past, present and future of CytoSorb
30:36
9
CytoSorb in various fields of application: Liver failure
CytoSorb in various fields of application: Liver failure
15:04
10
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
11:34
1. Herzchirurgisches CytoSorb Anwendertreffen | 2019 | Wiesbaden
1/8 videos
1
Introduction
Introduction
10:17
2
Impact of Cytokine Removal during Cardiopulmonary Bypass with CytoSorb
Impact of Cytokine Removal during Cardiopulmonary Bypass with CytoSorb
13:39
3
CytoSorb - Anwendung bei Endokarditis
CytoSorb - Anwendung bei Endokarditis
13:20
4
CytoSorb bei Aortendissektion
CytoSorb bei Aortendissektion
19:09
5
Impact of Cytokine Removal during Cardiopulmonary Bypass with CytoSorb
Impact of Cytokine Removal during Cardiopulmonary Bypass with CytoSorb
08:22
6
CytoSorb Anwendung postoperativ 5 Jahre Erfahrungen im HDZ
CytoSorb Anwendung postoperativ 5 Jahre Erfahrungen im HDZ
12:24
7
CytoSorb und ECMO - Ergebnisse aus Ulm
CytoSorb und ECMO - Ergebnisse aus Ulm
30:37
8
Intraoperative removal of Ticagrelor to reduce bleeding complications in emergency cardiac Surgery
Intraoperative removal of Ticagrelor to reduce bleeding complications in emergency cardiac Surgery
13:43
5. CytoSorb Anwendertreffen DACH | 2018 | Leipzig
1/5 videos
1
01 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
01 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
01:02:34
2
02 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
02 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
28:22
3
03 Praktische Aspekte und neue Erfahrungen im Bereich Rhabdomyolyse
03 Praktische Aspekte und neue Erfahrungen im Bereich Rhabdomyolyse
25:12
4
04 Praktische Aspekte und neue Erfahrungen im Bereich Leberversagen
04 Praktische Aspekte und neue Erfahrungen im Bereich Leberversagen
35:21
5
Dr. Christian Steiner, CytoSorbents | 2018 | Leipzig
Dr. Christian Steiner, CytoSorbents | 2018 | Leipzig
10:46
EACTS | 2018 | Milan | Symposium Webcast
1/5 videos
1
MOF in ECMO patients and the impact of CytoSorb therapy – 3 years’ experience
MOF in ECMO patients and the impact of CytoSorb therapy – 3 years’ experience
09:19
2
Improved outcome of patients undergoing heart transplant with CytoSorb | EACTS | 2018 | Milan
Improved outcome of patients undergoing heart transplant with CytoSorb | EACTS | 2018 | Milan
09:34
3
Clinical effects of intraoperative hemoadsorption in acute infective endocarditis – A case series
Clinical effects of intraoperative hemoadsorption in acute infective endocarditis – A case series
10:57
4
5
Intraoperative removal of Ticagrelor to reduce bleeding complications... | EACTS | 2018 | Milan
Intraoperative removal of Ticagrelor to reduce bleeding complications... | EACTS | 2018 | Milan
09:13
CytoSorb Aufbau | Anleitung
1/6 videos
1
CytoSorb-Aufbau: Einsatz im kardiopulmonalen Bypass
CytoSorb-Aufbau: Einsatz im kardiopulmonalen Bypass
02:33
2
CytoSorb-Aufbau: Austausch des Adsorbers
CytoSorb-Aufbau: Austausch des Adsorbers
02:15
3
CytoSorb-Aufbau: Einsatz hinter dem Dialysator
CytoSorb-Aufbau: Einsatz hinter dem Dialysator
03:09
4
CytoSorb Aufbau: Einsatz vor dem Dialysator
CytoSorb Aufbau: Einsatz vor dem Dialysator
02:57
5
Hämoperfusion Aufbau für Stand-Alone Anwendung von CytoSorb
Hämoperfusion Aufbau für Stand-Alone Anwendung von CytoSorb
02:09
6
CytoSorb ECMO Integration - Deutsch - Animation
CytoSorb ECMO Integration - Deutsch - Animation
03:36
CytoSorb Testimonials
1/6 videos
1
Future – What do you think about the future of CytoSorb?
Future – What do you think about the future of CytoSorb?
01:56
2
Safety – How would you describe the safety profile of CytoSorb?
Safety – How would you describe the safety profile of CytoSorb?
46
3
Ease of use – How easy is the set-up of CytoSorb?
Ease of use – How easy is the set-up of CytoSorb?
01:05
4
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
04:37
5
CytoSorb Testimonials
CytoSorb Testimonials
03:30
6
Early use – When should CytoSorb be started in septic shock?
Early use – When should CytoSorb be started in septic shock?
01:15

Literaturliste zur CytoSorb®- Therapie

Logo und Produktbilder